Ginger Lynch Landy, Co-Director, NY ALFA was quoted in a recent ALFA Update article discussing the barriers certain state’s regulations create that limit assisted living providers from participating in federal healthcare reform. She highlighted NY ALFA’s role in the progress New York State has made over the last several years with respect to assisted living policy and how it supports ACA objectives.
Ginger Lynch Landy, Co- Director, NY ALFA has been appointed to the Medicaid Redesign Team’s Affordable Housing Work Group.
NY ALFA, represented by Ginger Lynch Landy, Co- Director, has been an active participant in the Department of Health’s Assisted Living Architectural Work Group.
Learn more about the Assisted Living Architectural Work Group meetings.
A new ABC News article presents recent studies on new ways to diagnose Alzheimer’s disease. The research indicates that examining vision, balance, and gait problems may be effective and less intrusive methods for diagnosing individuals with the disease.
The New York Times has run a couple relevant editorials within the past week. Two recent New York Times’ articles: “Moving Murray” discusses the decision making process that the author’s own father went through, when deciding whether to move into an assisted living community, and “Our Irrational Fear of Forgetting” describes a nationwide intense fear of getting Alzheimer’s.
Let us know what you think by commenting on these articles below.
The New York Chapter of the Assisted Living Federation of America (NY ALFA), representing 47 professionally managed assisted living providers and over 4,100 senior residents throughout New York State, is in full support of S.188/A.3883. This bill would require residential health care facilities, adult day health care programs, and continuing care retirement communities that advertise themselves as providing Alzheimer’s and dementia special care to disclose the form of care or treatment provided that distinguishes it as being especially suitable for persons diagnosed with Alzheimer’s disease or dementia.
Alzheimer’s Disease and dementia are devastating illnesses that often make it difficult for families to continue to care for their loved ones at home. There are numerous housing and supportive services options available in New York, and it can be a challenging and confusing process for families to determine which programs and options will best suit their needs. This bill will ensure that clear, reliable information is available to consumers that will help them make informed decisions with respect to the care they or their family members require.
Currently, assisted living residences that provide Alzheimer’s and dementia care, known as special needs assisted living residences, are required to disclose the form of care they provide to their residents. This bill will ensure that consumers have access to uniform disclosures across the long term care continuum and to necessary information with respect to the various housing and supportive services options available in New York State.
Therefore, NY ALFA is in full support of S.188/A.3883 and urges the Legislature to pass the measure as soon as possible.
If you have any questions, please contact Nancy Hodes or Ginger Landy at 518-465-8303 at your convenience.